Avoiding diabetic ketoacidosis in perioperative and procedure settings
File version
Accepted Manuscript (AM)
Author(s)
Kerr, Kathryn
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
Size
File type(s)
Location
License
Abstract
Sodium-glucose co-transporter 2 inhibitors (SGLT2i) are a relatively new class of oral medications for the treatment of type 2 diabetes. While they are particularly helpful for managing blood glucose in diabetic patients with cardiovascular comorbidities, they also come with side-effects and potentially life-threatening risks. This article describes how to safely manage these patients when fasting in perioperative and procedure settings.
Journal Title
Australian Nursing and Midwifery Journal
Conference Title
Book Title
Edition
Volume
27
Issue
2
Thesis Type
Degree Program
School
Publisher link
DOI
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
© 2021 Australian Nursing Journal. This is the author-manuscript version of the paper. Reproduced in accordance with the copyright policy of the publisher. Please refer to the journal link for access to the definitive, published version.
Item Access Status
Note
Access the data
Related item(s)
Subject
Nursing
Persistent link to this record
Citation
Ray-Barruel, G; Kerr, K, Avoiding diabetic ketoacidosis in perioperative and procedure settings, Australian Nursing and Midwifery Journal, 2021, 27 (2), pp. 28-30